drugset / Trial / NCT03067415

Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily

NCT03067415

Phase 2 Unknown 98 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupTriple-blindTreatment

Summary

Exploratory trial to evaluate the efficacy and safety of D565H twice daily versus D565 once daily.

Timeline

Start
2017-03-30
Primary completion
2017-09-10
Completion
2017-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule 25 ug/ml
Subject Latanoprost Small molecule 50 ug/ml